Depressive Disorders - Iceland | Statista Market Forecast

Revenue in the Depressive Disorders market is projected to reach US$10.68m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.48%, resulting in a market volume of US$11.49m by 2029.
In global comparison, most revenue will be generated United States (US$6.26bn in 2024).
In relation to total population figures, per person revenues of US$652.30 are generated in 2024.

Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.

The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.

Antidepressant drugs
Selective serotonin reuptake inhibitors (SSRIs)
Serotonin norepinephrine reuptake inhibitor (SNRIs)
Serotonin modulators
Tricyclic and tetracyclic antidepressants

Psychotherapy
Mood stabilizers
Anti-anxiety and stimulant medications
Behavioral therapy

The Depressive Disorders market in Iceland has been witnessing significant growth in recent years.

Customer preferences: Customers in Iceland have shown a growing demand for effective treatments and therapies for depressive disorders. They are increasingly seeking out innovative and personalized solutions that can help them manage their mental health effectively. With the rising awareness about mental health issues and the stigma surrounding them slowly diminishing, more people are willing to seek professional help and invest in their well-being. As a result, the market for depressive disorders in Iceland has been expanding.

Trends in the market: One of the key trends in the Depressive Disorders market in Iceland is the increasing use of technology and digital solutions. Telemedicine and online therapy platforms have gained popularity, allowing individuals to access mental health services remotely. This trend has been accelerated by the COVID-19 pandemic, which has highlighted the importance of remote healthcare services. Online platforms provide convenience, privacy, and accessibility to individuals seeking treatment for depressive disorders, thereby driving market growth.Another trend in the market is the growing focus on holistic approaches to mental health. Many individuals in Iceland are now looking beyond traditional pharmaceutical treatments and exploring alternative therapies such as mindfulness, meditation, and yoga. These holistic approaches aim to address the root causes of depressive disorders and promote overall well-being. The market has responded to this trend by offering a wide range of products and services that cater to these preferences.

Local special circumstances: Iceland has a unique geographical and cultural landscape that influences the Depressive Disorders market. The country's natural beauty, including its hot springs, waterfalls, and geysers, has made it a popular destination for wellness tourism. Many individuals visit Iceland to relax, rejuvenate, and improve their mental well-being. This has created opportunities for the market to develop specialized services and products that cater to the needs of wellness tourists.

Underlying macroeconomic factors: The strong economic growth in Iceland has contributed to the development of the Depressive Disorders market. As the country's economy has expanded, individuals have had more disposable income to spend on mental health treatments and therapies. Additionally, the government has taken steps to improve mental health services and reduce the stigma associated with depressive disorders. This has created a supportive environment for market growth.In conclusion, the Depressive Disorders market in Iceland is experiencing growth due to increasing customer preferences for effective treatments, the adoption of technology and digital solutions, the focus on holistic approaches to mental health, unique local circumstances, and the favorable macroeconomic factors. The market is expected to continue expanding as individuals prioritize their mental well-being and seek out innovative solutions to manage depressive disorders.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.